Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12124436rdf:typepubmed:Citationlld:pubmed
pubmed-article:12124436lifeskim:mentionsumls-concept:C0010453lld:lifeskim
pubmed-article:12124436lifeskim:mentionsumls-concept:C0006104lld:lifeskim
pubmed-article:12124436lifeskim:mentionsumls-concept:C0567416lld:lifeskim
pubmed-article:12124436lifeskim:mentionsumls-concept:C1512035lld:lifeskim
pubmed-article:12124436lifeskim:mentionsumls-concept:C0025462lld:lifeskim
pubmed-article:12124436lifeskim:mentionsumls-concept:C1704448lld:lifeskim
pubmed-article:12124436lifeskim:mentionsumls-concept:C0671702lld:lifeskim
pubmed-article:12124436lifeskim:mentionsumls-concept:C0038952lld:lifeskim
pubmed-article:12124436lifeskim:mentionsumls-concept:C1335280lld:lifeskim
pubmed-article:12124436lifeskim:mentionsumls-concept:C1706044lld:lifeskim
pubmed-article:12124436lifeskim:mentionsumls-concept:C1514562lld:lifeskim
pubmed-article:12124436lifeskim:mentionsumls-concept:C0851285lld:lifeskim
pubmed-article:12124436lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:12124436pubmed:issue2lld:pubmed
pubmed-article:12124436pubmed:dateCreated2002-7-18lld:pubmed
pubmed-article:12124436pubmed:abstractTextTo examine the roles of Shp-2, a cytoplasmic tyrosine phosphatase, in neuronal survival, we generated and used recombinant adenoviruses expressing wild type and phosphatase-inactive (C/S), phosphatase domain-deficient (delta P) and constitutively active (D61A and E76A) mutants of Shp-2. We found that wild-type Shp-2 enhanced brain-derived neurotrophic factor (BDNF)-promoted survival of cultured ventral mesencephalic dopaminergic neurons. In contrast, the C/S and delta P mutants of Shp-2 did not affect survival. In addition, the constitutively active D61A and E76A mutants mimicked BDNF and promoted survival. Furthermore, to examine the effects of BIT/SHPS-1, a substrate of Shp-2, on the BDNF-promoted survival, we generated adenovirus vectors expressing wild-type BIT/SHPS-1 and its 4F mutant in which all tyrosine residues in the cytoplasmic domain of BIT/SHPS-1 were replaced with phenylalanine. We found that BDNF-promoted survival of cultured mesencephalic dopaminergic neurons was enhanced by expression of the 4F mutant but not of wild-type BIT/SHPS-1. In addition, we found that co-expression of wild-type BIT/SHPS-1 with Shp-2 significantly enhanced the survival-promoting effect of BDNF on cultured mesencephalic dopaminergic neurons. These results indicated that Shp-2 positively regulates the survival-promoting effect of BDNF on cultured ventral mesencephalic dopaminergic neurons. Dephosphorylation of BIT/SHPS-1 by Shp-2 may participate in BDNF-stimulated survival signaling.lld:pubmed
pubmed-article:12124436pubmed:languageenglld:pubmed
pubmed-article:12124436pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12124436pubmed:citationSubsetIMlld:pubmed
pubmed-article:12124436pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12124436pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12124436pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12124436pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12124436pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12124436pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12124436pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12124436pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12124436pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12124436pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12124436pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12124436pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12124436pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12124436pubmed:statusMEDLINElld:pubmed
pubmed-article:12124436pubmed:monthJullld:pubmed
pubmed-article:12124436pubmed:issn0022-3042lld:pubmed
pubmed-article:12124436pubmed:authorpubmed-author:YamadaMasashi...lld:pubmed
pubmed-article:12124436pubmed:authorpubmed-author:HatanakaHiros...lld:pubmed
pubmed-article:12124436pubmed:authorpubmed-author:ArakiToshiyuk...lld:pubmed
pubmed-article:12124436pubmed:authorpubmed-author:KoshimizuHisa...lld:pubmed
pubmed-article:12124436pubmed:authorpubmed-author:TakaiSatomiSlld:pubmed
pubmed-article:12124436pubmed:authorpubmed-author:NawaHiroyukiHlld:pubmed
pubmed-article:12124436pubmed:issnTypePrintlld:pubmed
pubmed-article:12124436pubmed:volume82lld:pubmed
pubmed-article:12124436pubmed:ownerNLMlld:pubmed
pubmed-article:12124436pubmed:authorsCompleteYlld:pubmed
pubmed-article:12124436pubmed:pagination353-64lld:pubmed
pubmed-article:12124436pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:12124436pubmed:meshHeadingpubmed-meshheading:12124436...lld:pubmed
pubmed-article:12124436pubmed:meshHeadingpubmed-meshheading:12124436...lld:pubmed
pubmed-article:12124436pubmed:meshHeadingpubmed-meshheading:12124436...lld:pubmed
pubmed-article:12124436pubmed:meshHeadingpubmed-meshheading:12124436...lld:pubmed
pubmed-article:12124436pubmed:meshHeadingpubmed-meshheading:12124436...lld:pubmed
pubmed-article:12124436pubmed:meshHeadingpubmed-meshheading:12124436...lld:pubmed
pubmed-article:12124436pubmed:meshHeadingpubmed-meshheading:12124436...lld:pubmed
pubmed-article:12124436pubmed:meshHeadingpubmed-meshheading:12124436...lld:pubmed
pubmed-article:12124436pubmed:meshHeadingpubmed-meshheading:12124436...lld:pubmed
pubmed-article:12124436pubmed:meshHeadingpubmed-meshheading:12124436...lld:pubmed
pubmed-article:12124436pubmed:meshHeadingpubmed-meshheading:12124436...lld:pubmed
pubmed-article:12124436pubmed:meshHeadingpubmed-meshheading:12124436...lld:pubmed
pubmed-article:12124436pubmed:meshHeadingpubmed-meshheading:12124436...lld:pubmed
pubmed-article:12124436pubmed:meshHeadingpubmed-meshheading:12124436...lld:pubmed
pubmed-article:12124436pubmed:meshHeadingpubmed-meshheading:12124436...lld:pubmed
pubmed-article:12124436pubmed:meshHeadingpubmed-meshheading:12124436...lld:pubmed
pubmed-article:12124436pubmed:meshHeadingpubmed-meshheading:12124436...lld:pubmed
pubmed-article:12124436pubmed:meshHeadingpubmed-meshheading:12124436...lld:pubmed
pubmed-article:12124436pubmed:meshHeadingpubmed-meshheading:12124436...lld:pubmed
pubmed-article:12124436pubmed:meshHeadingpubmed-meshheading:12124436...lld:pubmed
pubmed-article:12124436pubmed:meshHeadingpubmed-meshheading:12124436...lld:pubmed
pubmed-article:12124436pubmed:meshHeadingpubmed-meshheading:12124436...lld:pubmed
pubmed-article:12124436pubmed:meshHeadingpubmed-meshheading:12124436...lld:pubmed
pubmed-article:12124436pubmed:meshHeadingpubmed-meshheading:12124436...lld:pubmed
pubmed-article:12124436pubmed:meshHeadingpubmed-meshheading:12124436...lld:pubmed
pubmed-article:12124436pubmed:year2002lld:pubmed
pubmed-article:12124436pubmed:articleTitleShp-2 positively regulates brain-derived neurotrophic factor-promoted survival of cultured ventral mesencephalic dopaminergic neurons through a brain immunoglobulin-like molecule with tyrosine-based activation motifs/Shp substrate-1.lld:pubmed
pubmed-article:12124436pubmed:affiliationDivision of Protein Biosynthesis, Institute for Protein Research, Osaka University, Suita, Japan.lld:pubmed
pubmed-article:12124436pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12124436pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12124436lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12124436lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12124436lld:pubmed